171596-42-2Relevant articles and documents
Preparation method of tadalafil intermediate impurity
-
Paragraph 0029; 0069-0071; 0076-0078; 0083-0085; 0090-0094, (2021/08/07)
A preparation method of a tadalafil intermediate impurity comprises the following steps: firstly, fully dissolving raw materials in an isomerization solvent, sequentially carrying out a heating reflux reaction and vacuum concentration to obtain a residue I, adding an alkaline solution and an extraction solvent into the residue I, sequentially carrying out room temperature stirring and standing, then taking an organic phase, and carrying out vacuum evaporation to dryness to obtain a residue II; and adding a resolving solvent into the residue II, sequentially carrying out heating reflux reaction, natural stirring crystallization and filtration to obtain filtrate and a filter cake, and finally drying the filter cake to obtain an intermediate impurity, wherein the temperature of natural stirring crystallization is 30-60 DEG C. According to the preparation method, the principle that the intermediates and the reaction byproducts have different solubilities in the resolving solvents at different temperatures is utilized, the intermediates and the reaction byproducts are resolved, the preparation efficiency is high, the cost is low, and the purity of the prepared intermediates is high.
3,4-methylenedioxyphenyl substituted tetrahydro-beta-carboline piperazine dione derivative and uses thereof
-
Paragraph 0105; 0107; 0108; 0109, (2018/09/11)
The present invention relates to a 3,4-methylenedioxyphenyl substituted tetrahydro-beta-carboline piperazine dione derivative and uses thereof, and specifically discloses a compound represented by a formula I, or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, wherein each group is defined in the specification. According to the present invention, the compound has dual inhibitory activity on acetylcholinesterase and phosphodiesterase 5, and has good blood-brain barrier permeability, such that the compound can be used for preparing drugs for treatment and/or prevention ofAlzheimer's diseases. The formula I is defined in the specification.
Preparation method of tadalafil
-
Paragraph 0053; 0054, (2017/08/29)
The invention discloses a preparation method of tadalafil, starting material D-Tryptophan methyl ester hydrochloride is reacted with oxalyl chloride to obtain an intermediate III, and the final product tadalafil (I) is obtained through cyclization, Grignard reaction, asymmetric reduction, substitution and condensation reaction. The use of national control chemical piperonal is avoided, an intermediate VI can be highly-selectively obtained by the asymmetric reduction, and the method has the advantages of simple postprocessing, short synthesis steps and high product total yield, and is suitable for industrialized production.